Indicators of biochemical control of diabetes mellitus during limited availability of health service in the context of hypoglycemic therapy
Wiadomości Lekarskie · 2024
DOI: 10.36740/wlek202407103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2024. Verfasst von Marcin Kleibert und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHAIR AND DEPARTMENT OF EXPERIMENTAL AND CLINICAL PHYSIOLOGY, LABORATORY OF CENTER FOR PRECLINICAL RESEARCH, MEDICAL UNIVERSITY OF WARSAW, WARSAW, PO…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycated Hemoglobin, Hypoglycemic Agents, COVID-19. Die Arbeit nennt 23 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Type 2 diabetes mellitus (T2DM) is a widespread disease that leads to many complications if not adequately controlled. The pandemic and its limitations on healthcare access impaired the management of chronic conditions. The aim of our study was to examine its effects in context of different antidiabetic therapies on key health related factors in patients with T2DM. Materials and Methods: To the study we enrolled 598 adult patients with diagnosed T2DM treated in diabetology outpatient department of the University Clinical Centre (UCC) of the Medical University of Warsaw. Data on body weight, glycated hemoglobin (HbA1c), and creatinine concentration were collected throughout the first COVID-19 pandemic wave and compared to the results obtained before the 4th of March, 2020 (1st confirmed COVID-19 case in Poland).
Results
The HbA1c mean baseline level was 7.15% (±1.39) and increased significantly (7.34% (±1.37), p=0.02) during observation. Importantly, the attendance of patients for HbA1c testing decreased by 57.82% in comparison to the pre-pandemic period. Similarly, creatinine concentrations increased (from 1.27 mg/dl (±0.76) to 1.34 mg/dl (±1.02), (p=0.004)). The increase in creatinine concentration was significantly lower in the group treated with regimens including metformin compared to other regimens. Somewhat surprisingly, the mean body mass remained unchanged.
Conclusions
The pandemic period had a significant impact on the tested biochemical parameters. The lesser changes of renal parameters in the group of patients treated with metformin confirms its nephroprotective effect and its value as a first-line treatment in T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHAIR AND DEPARTMENT OF EXPERIMENTAL AND CLINICAL PHYSIOLOGY, LABORATORY OF CENTER FOR PRECLINICAL RESEARCH, MEDICAL UNIVERSITY OF WARSAW, WARSAW, POLAND.
- DEPARTMENT OF ENDOCRINOLOGY, CENTRE OF POSTGRADUATE MEDICAL EDUCATION, BIELANSKI HOSPITAL, WARSAW, POLAND.
- FACULTY OF MEDICINE, MEDICAL UNIVERSITY OF WARSAW, WARSAW, POLAND.
- INTERDISCIPLINARY CENTRE FOR MATHEMATICAL AND COMPUTATIONAL MODELLING, UNIVERSITY OF WARSAW, WARSAW, POLAND.
Zitieren
APA
Kleibert, M., Mrozikiewicz-Rakowska, B., Korycka, K., Płachta, I., Bąk, P. M., Bałut, D., Zieliński, J., & Zgliczyński, W. (2024). Indicators of biochemical control of diabetes mellitus during limited availability of health service in the context of hypoglycemic therapy. Wiadomości Lekarskie. https://doi.org/10.36740/wlek202407103
Vancouver
Kleibert M, Mrozikiewicz-Rakowska B, Korycka K, Płachta I, Bąk PM, Bałut D, et al. Indicators of biochemical control of diabetes mellitus during limited availability of health service in the context of hypoglycemic therapy. Wiadomości Lekarskie. 2024. doi:10.36740/wlek202407103
BibTeX
@article{Kleibert2024,
author = {Kleibert, Marcin and Mrozikiewicz-Rakowska, Beata and Korycka, Klaudia and Płachta, Iga and Bąk, Patrycja Małgorzata and Bałut, Daniel and Zieliński, Jakub and Zgliczyński, Wojciech},
title = {Indicators of biochemical control of diabetes mellitus during limited availability of health service in the context of hypoglycemic therapy},
journal = {Wiadomości Lekarskie},
year = {2024},
doi = {10.36740/wlek202407103}
}
EUVIMED